Inventiva (IVA) Change in Receivables (2019 - 2025)
Inventiva's (IVA) quarterly Change in Receivables came in at -$16.4 million in Q2 2025, down 307.65% quarter-over-quarter from -$4.0 million in Q4 2022.
Inventiva (IVA) Change in Receivables (2019 - 2025) Analysis & Trends
Inventiva's Change in Receivables history runs 5 years deep, the most recent figure standing at -$16.4 million for Q2 2025.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to -$16.4 million in Q2 2025; TTM through Jun 2025 was -$16.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $989437.0, down 67.0% from the prior year.
- Change in Receivables slipped to -$16.4 million in Q2 2025 per IVA's latest filing, from -$4.0 million in the prior quarter.
- Across five years, Change in Receivables topped out at $4.1 million in Q3 2022 and bottomed at -$16.4 million in Q2 2025.
- The 3-year median for Change in Receivables is -$133428.9 (2021), against an average of -$2.8 million.
- Across the five-year window, Change in Receivables soared 132.11% in 2021 and plunged 4718.42% in 2022, its largest moves.
- Year by year, Change in Receivables stood at -$83509.9 in 2021, then plunged by 4718.42% to -$4.0 million in 2022, then slumped by 307.65% to -$16.4 million in 2025.
- Per Business Quant, the three latest IVA Change in Receivables figures stand at -$16.4 million (Q2 2025), -$4.0 million (Q4 2022), and $4.1 million (Q3 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -16.40 Mn |
| Jun 30, 2025 | -16.40 Mn |
| Dec 31, 2022 | -4.02 Mn |
| Dec 31, 2022 | -4.02 Mn |
| Sep 22, 2022 | 4.06 Mn |
| Sep 22, 2022 | 4.06 Mn |
| Dec 31, 2021 | -83,509.88 |
| Dec 31, 2021 | -83,509.88 |
| Jun 30, 2021 | 95,137.44 |
| Jun 30, 2021 | 95,137.44 |
| Mar 31, 2021 | -183,347.89 |
| Mar 31, 2021 | -183,347.89 |
| Dec 31, 2020 | -482,877.39 |
| Dec 31, 2020 | -482,877.39 |
| Jun 30, 2020 | -296,292.77 |
| Jun 30, 2020 | -296,292.77 |
| Mar 31, 2020 | -150,135.71 |
| Mar 31, 2020 | -150,135.71 |
| Dec 31, 2019 | 1.81 Mn |
| Dec 31, 2019 | 1.81 Mn |